This compound is primarily utilized in the field of medicinal chemistry, where it serves as a key intermediate in the synthesis of various pharmaceutical agents. Its unique structure, featuring both a phosphonomethyl group and a carboxylic acid moiety, makes it particularly valuable in the development of enzyme inhibitors. Specifically, it is often employed in the design of drugs targeting enzymes involved in amino acid metabolism, such as glutamate racemase and other related enzymes. Additionally, its stereochemistry plays a crucial role in enhancing the selectivity and efficacy of the resulting inhibitors, making it a critical component in the creation of potent and specific therapeutic agents.